Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Eltrombopag (Primary) ; Immune globulin
- Indications Immune thrombocytopenic purpura
- Focus Therapeutic Use
- Acronyms BRIDGING ITP
- 16 Mar 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2018 as per ClinicalTrials.gov record.
- 16 Mar 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018 as per ClinicalTrials.gov record.
- 07 Apr 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016, according to to ClinicalTrials.gov record.